Unicharm (OTCMKTS:UNICY - Get Free Report) was the recipient of a large decrease in short interest in August. As of August 15th, there was short interest totaling 11,000 shares, adecreaseof75.3% from the July 31st total of 44,600 shares. Based on an average daily volume of 2,762,700 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 2,762,700 shares, the days-to-cover ratio is currently 0.0 days.
Unicharm Trading Down 0.3%
UNICY traded down $0.01 on Monday, reaching $3.29. 20,283 shares of the company's stock were exchanged, compared to its average volume of 617,874. The company's 50 day moving average is $3.43 and its 200-day moving average is $3.85. The company has a market cap of $11.53 billion, a price-to-earnings ratio of 16.45 and a beta of 0.23. Unicharm has a twelve month low of $3.06 and a twelve month high of $8.10. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.87 and a current ratio of 2.32.
Unicharm (OTCMKTS:UNICY - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.03 earnings per share (EPS) for the quarter. The business had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.81 billion. Equities analysts predict that Unicharm will post 0.17 earnings per share for the current year.
Unicharm Company Profile
(
Get Free Report)
Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.
Further Reading
Before you consider Unicharm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicharm wasn't on the list.
While Unicharm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.